V - REFERENCES
Allegretto, E. A., McClurg, M. R., Lazarchik, S. B., Clemm, D.
L., Kerner, S. A., Elgort, M. G., Boehm, M. F., White, S. K., Pike, J. W., and
Heyman, R. A. (1993). Transactivation properties of retinoic acid and retinoid
X receptors in mammalian cells and yeast. Correlation with hormone binding and
effects of metabolism. J. Biol. Chem. 268, 26625-26633.
Allenby, G., Bocquel, M. T., Saunders, M., Kazmer, S., Speck,
J., Rosenberger, M., Lovey, A., Kastner, P., Grippo, J. F., and Chambon, P.
(1993). Retinoic acid receptors and retinoid X receptors: interactions with
endogenous retinoic acids. Proc. Natl. Acad. Sci. U.S.A. 90, 30-34.
Aman, P., Panagopoulos, I., Lassen, C., Fioretos, T.,
Mencinger, M., Toresson, H., Hoglund, M., Forster, A., Rabbitts, T. H., and
Ron, D., (1996). Expression patterns of the human sarcoma-associated genes FUS
and EWS and the genomic structure of FUS. Genomics 37, 1-8.
Beaschtold, H., Kuroda, M., Sock, J., Ron, D., and Lopez, B.L.
(1999). Human 75 Kda DNA-pairing Protein is identical to the pro-oncoprotein
TLS/FUS and is able to promote D-loop formation. J. Biol. Chem. 274,
34337-34342.
Bertolotti, A., Lutz, Y., Heard, D. J., Chambon, P., and Tora,
L. (1996). hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the
pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA
polymerase II. EMBO J. 15, 5022-5031.
Bertolotti, A., Melot, T., Acker, J., Vigneron, M., Delattre,
O., and Tora, L. (1998). EWS, but not EWS-FLI-1, is associated with both TFIID
and RNA polymerase II: interactions between two members of the TET family, EWS
and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. Mol. Cell.
Biol. 18, 1489-1497.
Bretnach, R., and Chambon, P. (1981). Organization and
expression of eukaryotic split genes coding for proteins. Annu. Rev.
Biochem., 50, 349-384.
Breitman, T. R., Selonick, S. E., and Collins, S. J. (1980).
Induction of differentiation of the human promyelocytic leukemia cell line
(HL-60) by retinoic acid. Proc. Natl. Acad. Sci. U.S.A. 77,
2936-2940.
Burd, C. G., and Dreyfuss, G. (1994). RNA binding specificity
of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA
splicing. EMBO J. 13, 1197-1204.
Chambon, P. (1996). A decade of molecular biology of retinoic
acid receptors. FASEB J. 10, 940-954.
Chen, Z., Brand, N.J., Chen A., Chen, S.J., Tong, J.H., Wang,
Z.Y., Waxman, S., and Zelent, A. (1993). Fusion between a novel
krüpper-like zinc finger gene and the retinoic acid receptor-alpha locus
due to a variant t(11 ;17) translocation associated with acute
promyelocytic leukemia. EMBO J. 12, 1161-1167.
Cho, E.J., Takagi, T., Moore, C.R., Buratowski, S. (1997).
mRNA capping enzyme is recruited to the transcription complex by
phosphorylation of the RNA polymerase II carboxy terminal domain. Genes Dev
11, 3319-3326.
Chomienne, C., Fenaux, P., and Degos, L. (1996). Retinoid
differentiation therapy in promyelocytic leukemia. FASEB J. 10,
1025-1030.
Cooper, D.L., and Dougherty G.J. (1995). To metastasize or
not? Selection of CD44 splice sites. Nat. Med. 1, 635-637.
Croft, L., Schandorff, S., Clark, F., Burrage, K., Arctander,
P., and Mattick, J.S. (2000). ISIS, the intron information system, reveals the
high frequency of alternative splicing in the human genome. Nat. Genet.
24, 340-341.
Crozat, A., Aman, P., Mandahl, N., and Ron, D. (1993). Fusion
of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature
363, 640-644.
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot,
T., Peter, M., Kovar, H., Joubert, I., de Jong, P., and Rouleau, G. (1992).
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation
in human tumours. Nature 359, 162-165.
Douer, D., and Koeffler, H. P. (1982). Retinoic acid.
Inhibition of the clonal growth of human myeloid leukemia cells. J. clin.
invest. 69, 277-283.
Felsenfeld, G., Boyes, J., Chung, J., Clark, D., and
Studitsky, V. (1996). Chromatin structure and gene expression. Proc. natl.
acad. sci. u.s.a. 93, 9384-9388.
Fenaux, P., Chastang, C., Chomienne, C. and Degos, L.
(1994).All-trans retinoic acid (ATRA) in combination with chemotherapy improves
survival in newly diagnosed acute promyelocytic leukemia (APL). Lancet,
343, 1033.
Ge, H., Si, Y., and Roeder, R. G. (1998). Isolation of cDNAs
encoding novel transcription coactivators p52 and p75 reveals an alternate
regulatory mechanism of transcriptional activation. EMBO J. 17,
6723-6729.
Giguère, V. (1994). Retinoic acid receptors and
cellular retinoid binding proteins: complex interplay in retinoid signaling.
Endocr. Rev. 15, 61-79.
Giguere, V., Ong, E. S., Segui, P., and Evans, R. M. (1987).
Identification of a receptor for the morphogen retinoic acid. Nature
330, 624-629.
Gratas, C., Menot, M. L., Dresch, C., and Chomienne, C.
(1993). Retinoic acid supports granulocytic but not erythroid differentiation
of myeloid progenitors in normal bone marrow cells. Leukemia 7,
1156-1162.
Green S. and Chambon P. (1986). Carcinogenesis: a superfamily
of potentially oncogenic hormone receptors. Nature 324, 615-617.
Hallier, M., Lerga, A., Barnache, S., Tavitian, A.,
Moreau-Gachelin F. , (1998). The transcription factor Spi-1/PU.1 interacts with
the potential splicing factor TLS. J. Biol. Chem..273(9), 4838-42.
Hicks, G.G., Singh, N., Nashabi, A., Mai, S., Bozeck, G.,
Klewes, L., Arapovic, D., White, E.K., Koury, M.J., Oltz, E.M., Van Kaer, L.,
and Ruley, E.H. (2000). Fus deficiency in mice results in defective
B-lymphocyte development and activation, high levels of chromosomal instability
and perinatal death. Nature Genetics 24, 175-179.
Hirose, Y., and Manley, J.L. (1998). RNA polymerase II is an
essential mRNA polyadenylation factor. Nature 395, 93-96.
Ichikawa, H., Shimizu, K., Katsu, R., and Ohki, M. (1999) Dual
transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred
by two N-terminal domains of FUS (TLS). Mol. Cell. Biol. 15,
2513-2526.
Kastner, P., Grondona, J. M., Mark, M., Gansmuller, A.,
LeMeur, M., Décimo, D., Vonesch, J. L., Dollé, P., and Chambon,
P. (1994). Genetic analysis of RXR alpha developmental function: convergence of
RXR and RAR signaling pathways in heart and eye morphogenesis. Cell
78, 987-1003.
Krust, A., Kastner, P., Petkovich, M., Zelent, A., and
Chambon, P. (1989). A third human retinoic acid receptor, hRAR-gamma. Proc.
natl. acad. sci. u.s.a. 86, 5310-5314.
Lerga, A., Hallier, M., Delva, L., Orvain, C., Gallais, I.,
Marie, J., Moreau-Gachelin F. (2001), Identification of an RNA binding
specificity for the potential splicing factor TLS.J .Biol .Chem..
276(9), 6807-16.
Mills, K.I., Walsh, V., Gilkes, A.F., Sweeney, M.C., Mirza,
T., Woodgate L.J., Brown G. and Burnett A.K. (2000). High FUS/TLS expression in
acute myeloid leukaemia samples. Brit. J. Hem. 108, 316-321
Misteli, T. (2000). Cell biology of transcription and pre-mRNA
splicing: nuclear architecture meets nuclear function. J Cell Sci 113
11, 1841-1849.
Pereira, D.S., Dorrell, C., Ito, C.Y., Gan, O.I., Murdoch,
B., Rao, V.N., Zou, J.P., Reddy, E.S., and Dick, J.E. (1998). Retroviral
transduction of TLS/ERG initiates a leukemogenic program in normal human
hematopoietic cells. Proc. Natl. Acad. Sci. USA 95, 8239-8244..
Perroti, D., Bonatti, S., Trotta, R., Martinez, R., Skorski,
T., Salomoni, P., Grassili, E., Lozzo, R.V., Cooper,D. R., and Calabretta B.
(1998). TLS/FUS a pro-oncogene involved in multiple chromosomal translocations,
is a novel regulator of BCR/ABL-mediated leukemogenesis. EMBO J. 17,
4442-4455.
Petkovich, M., Brand, N.J., Krust, A., and Chambon, P. (1987).
A human retinoic acid receptor which belongs to the family of nuclear
receptors. Nature 330, 444-450.
Philips, A. V., and Cooper, T. A. (2000). RNA processing and
human disease. Cell. Mol. Life. Sci 57, 235-249.
Rabbits, T.H., Foster, A., Larson, R., Nathan P. (1993).
Fusion of the dominant negative transcription regulator CHOP with a novel gene
FUS by translocation t(12;16) in malignat liposarcoma. Nature Gen. 4,
175-180.
Powers, C.A., Mathur, M., Raaka, B.M., Ron, D., and Samuels,
H.S. (1998). TLS (Translocated in LipoSarcoma) is a high affinity interactor
for steroid, thyroid hormone and retinoid receptors. Molecular Endocrinology
12, 4-18.
Stickeler, E., Kittrell, F., Medina, D., and Berget, S.M.
(1999). Stage-specific changes in SR splicing factors and alternative splicing
in mammary tumorigenesis. Oncogene 18, 3574-3582.
Umesono, K. (1998). Endocrine signaling system mediated by
nuclear receptor. Nippon Rinsho 56, 1693-1698.
Uranishi, H., Tetsuka, T., Yamashita, M., Asamitsu, K.,
Shimizu, M., Itoh, M., and Okamoto, T. (2001). Involvement of the
pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B
p65-mediated transcription as a coactivator. J. Biol Chem 276,
13395-13401.
Valcarel, J., Gaur, R.K., Singh, R., and Green, M.R. (1996).
Interaction of U2AF RS region with pre-nRNA of branch point and promotion base
pairing with U2snRNA. Science 273, 1706-1709.
Yang, L., Embree, L.J., and Hickstein, D.D. (2000). TLS-ERG
leukemia fusion protein inhibits RNA splicing mediated by serine-arginine
proteins. Mol Cell Biol 20(10), 3345-54.
Yamamoto, K., Hamagushi, H., Nagata, K., Kobayashi, M.,
Tanimoto, F., and Taniwaki, M. (1997), Establishment of anovel human acute
myeloblastic leukemia cell line (YNH-1) with t(16;21), t(1;16) and 12q13
translocations. Leukemia 11, 599-608.
Zelenetz, A.D., Wilman, C.L., Chen, Z., Chen, S-J, Zelent, A.,
Macintyre, E., Veil, A., Cortes, J., Kantarjian, H. and Waxman, S. (1995)
Clinical and molecular characterization of a rare syndrome of acute
promyelocytic leukemia associated with translocation (11;17). Blood,
85, 1083-1094.
Zelent, A., Krust, A., Petkovich, M., Kastner, P. and Chambon,
P. (1989) Cloning of murine alpha and beta retinoic acid receptors and a novel
receptor gamma predominantly expressed in skin. Nature 339,
714-717.
Zinszner, H., Albalat, R., and Ron, D. (1994). A novel
effector domain from the RNA-binding protein TLS or EWS is required for
oncogenic transformation by CHOP. Genes and Dev 8, 2513-2526.
Zinszner, H., Immanuel, D., Yin, Y., Liang, F.X., and Ron, D.
(1997). A topogenic role for the oncogenic N-terminus of TLS: nucleolar
localization when transcription is inhibited. Oncogene 14, 451-461.
Zinszner, H., Sok, J., Immanuel, D., Yin, Y., and Ron, D.
(1997). TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic
shuttling. J. Cell. Sci. 110 , 1741-1750.
|
|
